GYRE THERAPEUTICS, INC. (GYRE) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $116.59M | +10.2% |
| 2024 | $105.76M | -6.8% |
| 2023 | $113.45M | +10.9% |
| 2022 | $102.29M | +1294.0% |
| 2021 | $7.34M | -65.0% |
| 2020 | $20.95M | — |
| 2018 | $6.0K | -99.4% |
| 2017 | $1.02M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $116.59M | +10.2% |
| 2024 | $105.76M | -6.8% |
| 2023 | $113.45M | +10.9% |
| 2022 | $102.29M | +1294.0% |
| 2021 | $7.34M | -65.0% |
| 2020 | $20.95M | — |
| 2018 | $6.0K | -99.4% |
| 2017 | $1.02M | — |